Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,545 | 104,139 | 109,424 | 122,061 | 226,751 |
| Marketable Securities | 138,454 | 184,512 | 219,301 | 194,332 | 225,443 |
| Receivables | 93,205 | 98,397 | 93,471 | 91,105 | 92,103 |
| Inventories | 92,977 | 96,063 | 96,799 | 100,588 | 103,662 |
| TOTAL | $376,114 | $498,334 | $533,411 | $526,210 | $667,018 |
| Non-Current Assets | |||||
| PPE Net | 181,617 | 183,512 | 193,646 | 191,279 | 189,767 |
| Investments And Advances | 8,281 | 37,209 | 17,394 | 0 | 0 |
| Intangibles | 689,467 | 703,789 | 738,363 | 741,456 | 755,368 |
| Other Non-Current Assets | 267,939 | 258,356 | 251,551 | 275,043 | 279,323 |
| TOTAL | $1,147,304 | $1,182,866 | $1,200,954 | $1,207,778 | $1,224,458 |
| Total Assets | $1,523,418 | $1,681,200 | $1,734,365 | $1,733,988 | $1,891,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,853 | 33,648 | 33,872 | 33,776 | 33,680 |
| Accounts payable and accrued liabilities | 17,261 | 15,220 | 12,933 | 13,983 | 14,843 |
| Accrued Expenses | 61,633 | 89,785 | 76,357 | 77,275 | 87,669 |
| TOTAL | $98,698 | $147,774 | $131,526 | $133,179 | $305,073 |
| Non-Current Liabilities | |||||
| Long Term Debt | 137,534 | 251,056 | 309,848 | 318,344 | 326,828 |
| Other Non-Current Liabilities | 519,145 | 507,360 | 522,868 | 525,829 | 539,874 |
| TOTAL | $656,679 | $758,416 | $832,716 | $844,173 | $876,827 |
| Total Liabilities | $755,377 | $906,190 | $964,242 | $977,352 | $1,181,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,989 | 45,952 | 45,882 | 45,824 | 45,437 |
| Common Shares | 46 | 46 | 46 | 46 | 45 |
| Retained earnings | -168,287 | -148,751 | -138,649 | -137,956 | -157,832 |
| Other shareholders' equity | -137 | -380 | -670 | -605 | -527 |
| TOTAL | $768,041 | $775,010 | $770,123 | $756,636 | $709,576 |
| Total Liabilities And Equity | $1,523,418 | $1,681,200 | $1,734,365 | $1,733,988 | $1,891,476 |